{"id":7484,"date":"2026-06-16T15:18:02","date_gmt":"2026-06-16T15:18:02","guid":{"rendered":"https:\/\/veilles-affaires-sociales.fr\/?p=7484"},"modified":"2026-06-16T15:18:02","modified_gmt":"2026-06-16T15:18:02","slug":"syndrome-de-cloves-lagence-europeenne-des-medicaments-autorise-la-mise-sur-le-marche-de-lalpelisib","status":"publish","type":"post","link":"https:\/\/veilles-affaires-sociales.fr\/?p=7484","title":{"rendered":"Syndrome de Cloves : l\u2019Agence europ\u00e9enne des m\u00e9dicaments autorise la mise sur le march\u00e9 de l\u2019alpelisib"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/presse.inserm.fr\/wp-content\/uploads\/2022\/02\/PhotoCP-web-1.png\" alt=\"PhotoCP-web-1.png\" \/><\/p>\n<p>L\u2019Agence europ\u00e9enne des m\u00e9dicaments vient d\u2019approuver l\u2019alpelisib pour le traitement des formes graves des syndromes hypertrophiques li\u00e9s au g\u00e8ne PIK3CA, dont le syndrome de Cloves. Cette avanc\u00e9e th\u00e9rapeutique est le fruit des travaux du Pr Guillaume Canaud et de son \u00e9quipe au sein de l\u2019unit\u00e9 de m\u00e9decine translationnelle et th\u00e9rapies cibl\u00e9es (UPCit\u00e9\/H\u00f4pital Necker-Enfants malades AP-HP\/Inserm).<\/p>\n<p>L\u2019article <a href=\"https:\/\/presse.inserm.fr\/syndrome-de-cloves-lagence-europeenne-des-medicaments-autorise-la-mise-sur-le-marche-de-lalpelisib\/73035\/\">Syndrome de Cloves : l\u2019Agence europ\u00e9enne des m\u00e9dicaments autorise la mise sur le march\u00e9 de l\u2019alpelisib<\/a> est apparu en premier sur <a href=\"https:\/\/presse.inserm.fr\/\">Salle de presse de l&rsquo;Inserm<\/a>.<\/p>\n<p>\u200b<a href=\"https:\/\/presse.inserm.fr\/syndrome-de-cloves-lagence-europeenne-des-medicaments-autorise-la-mise-sur-le-marche-de-lalpelisib\/73035\/\" target=\"_blank\" class=\"feedzy-rss-link-icon\">Lire la Suite<\/a>\u200bPACo_Automatique_Inserm via dfas-spat-doc-crdm-accueil on Inoreader<\/p>","protected":false},"excerpt":{"rendered":"<p>L\u2019Agence europ\u00e9enne des m\u00e9dicaments vient d\u2019approuver l\u2019alpelisib pour le traitement des formes graves des syndromes hypertrophiques li\u00e9s au g\u00e8ne PIK3CA, dont le syndrome de Cloves. Cette avanc\u00e9e th\u00e9rapeutique est le [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4209,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[3],"tags":[68],"class_list":["post-7484","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sante-publique-prevention-epidemiologie","tag-inserm"],"_links":{"self":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/7484","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7484"}],"version-history":[{"count":0,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/posts\/7484\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=\/wp\/v2\/media\/4209"}],"wp:attachment":[{"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7484"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7484"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/veilles-affaires-sociales.fr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7484"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}